In vitro, rapamycin promoted CML cells apoptosis and inhibited CML cell cycle through blocking mTOR signaling pathway (Li et al., 2019). The gene discussed is MTOR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.